Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury - Wikidata - wikimedia - TriplyDB

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury

http://www.wikidata.org/entity/Q34004845

about

Cellular treatments for spinal cord injury: the time is right for clinical trials Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy Generation of diverse neural cell types through direct conversion iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications Myelin damage and repair in pathologic CNS: challenges and prospects Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury Neurological disorders and the potential role for stem cells as a therapy Induction of pluripotency by defined factors The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery Stem cell transplantation for motor neuron disease: current approaches and future perspectives Molecular imaging in stem cell therapy for spinal cord injury Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells Functional Recovery from Neural Stem/Progenitor Cell Transplantation Combined with Treadmill Training in Mice with Chronic Spinal Cord Injury.Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats.Efficient derivation of multipotent neural stem/progenitor cells from non-human primate embryonic stem cells In vitro myelin formation using embryonic stem cells Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field Induced pluripotent stem cell-derived neural stem cell therapies for spinal cord injury iPS cell transplantation for traumatic spinal cord injury Stem cell therapy for central nerve system injuries: glial cells hold the key Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion Progress and bottleneck in induced pluripotency Rethinking differentiation: stem cells, regeneration, and plasticity Schwann-spheres derived from injured peripheral nerves in adult mice--their in vitro characterization and therapeutic potential A more efficient method to generate integration-free human iPS cells Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition.Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury.Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart.Converted neural cells: induced to a cure?Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.

P2860

Q24630772-7AFA25FF-3408-4215-AE47-5AFBC4B0D46A Q24635187-97C35120-1E8C-4E5F-B38E-5498427B3542 Q26749360-7A9E535F-AEF6-4C59-86A6-67310B6ACF4A Q26765258-41E28090-25E3-4AE2-A425-EF7EA967901F Q26765886-E896109F-A36D-461D-A710-55D31B002DC3 Q26772309-FDC4A38B-B122-416E-90E6-AF6D13606ADC Q26797407-9B7AA861-B7DC-4D98-9954-9D75FA1581C6 Q26799586-335A0784-3C42-4179-B9BC-88A9E3E59E56 Q26825854-D4BF7B40-BE7C-421B-A68C-0C89E68EAA83 Q26830211-39FBF6ED-8C17-404E-AC47-72201F65672B Q26830425-34F922DE-FBF5-40D4-81D5-34B2089D245B Q26860309-09B74443-8C1A-40C0-8539-91199CA89FBD Q26865055-96E55EEC-3C5F-43F9-8E81-7D201BBE2E75 Q26995278-39EE1A65-19BE-426A-8CAC-D51A7EC017C9 Q27023747-7F0D7D45-B391-4312-959D-E4FA10C1C491 Q27027581-8449543E-41EA-478B-BA7D-ABDB43316FF4 Q27320724-A4B87BA3-A81E-42C6-8F1F-DBB6FAC2CB2C Q27322391-3889BC15-A608-4C9F-B949-92C60DAE04BE Q27335801-F61C88DA-06A1-42B6-B6BE-EF3B17E6CA3F Q27345537-2EFE8A4A-F048-4015-A228-5378BFD62BA1 Q27682773-89088C55-35B7-4440-ACF1-E88B3DED15CB Q28073316-CA961854-352F-4307-86AA-074E4FC0D462 Q28081025-65E0A06D-BCEA-4669-BCFE-4556C6D08A35 Q28087189-5D8E7DE1-7691-4167-937C-F063FE738C47 Q28394140-9912B0DB-1EC3-4390-B9D8-71CB507CEB48 Q28543575-1A2743EA-4A6C-43E6-84DE-6D8D00726E88 Q28551495-B1458953-4EEF-42C4-A1C9-A66DA2B300E2 Q28652287-537AA294-C8CF-43C6-BC2C-5DB1D06B87CD Q28656516-4BE2F38E-D903-43C9-89D9-2B90EBB67EA0 Q28743246-238A8982-6509-4FD3-B00C-6A1ACA59B253 Q29615748-701C8D6E-9B37-471F-912E-1E33735027EE Q30516491-5A9C4B07-27BF-4C08-8BF2-B7F29F72949E Q30610413-9B2E1BE5-6A1A-441D-AA83-352AF77DB362 Q30844257-44AF0104-5F3B-43D1-B9B8-BF134CD43D5B Q33694696-33F776A8-5E11-4372-A12D-C2EA48E497BA Q33748399-537365CE-461F-4474-87BF-AEFC334BA396 Q33877155-8929C06A-DBD8-4FA5-A834-B9B4DBA5C16F Q33892673-373CC4C3-26E0-4E31-B372-EECFAE9E3C7A Q33924616-7DD237B2-EE2F-4DF1-8330-9AECFF55C241 Q33939904-2C63A0C9-F02A-4920-98FD-E97B5ACEC41A

P2860

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury

http://www.wikidata.org/entity/Q34004845

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic potential of appro ...... m cells for spinal cord injury

@ast

Therapeutic potential of appro ...... m cells for spinal cord injury

@en

Therapeutic potential of appro ...... m cells for spinal cord injury

@nl

type

label

Therapeutic potential of appro ...... m cells for spinal cord injury

@ast

Therapeutic potential of appro ...... m cells for spinal cord injury

@en

Therapeutic potential of appro ...... m cells for spinal cord injury

@nl

prefLabel

Therapeutic potential of appro ...... m cells for spinal cord injury

@ast

Therapeutic potential of appro ...... m cells for spinal cord injury

@en

Therapeutic potential of appro ...... m cells for spinal cord injury

@nl

P1433

Q34004845-51832D39-D760-4039-B943-7166472CF38B

P1476

Q34004845-983B2CF4-57BD-448C-A3D0-4A724934E851

P2093

Q34004845-04C4394B-0494-4660-B142-9C0418AB70F0

Q34004845-05A9F3E1-DABB-4097-9F42-011B5950B67D

Q34004845-06EBED6B-160E-45A9-8D8B-AA3DA5EFF392

Q34004845-11A34991-0B60-4222-9D83-BD9C9DEAEAB6

Q34004845-135CFED6-54B4-4FAC-88DD-68491BC3A03B

Q34004845-1D230F3F-EAE6-4A79-BBA0-748509152BC6

Q34004845-43B8F9D2-310E-4038-88E6-61BE48B02658

Q34004845-54EFE86D-351E-4794-BCF1-5C8E5C265643

Q34004845-5B2320BB-CDB2-469A-A88B-D464D4060EE7

Q34004845-72FC3A0C-49B7-470E-9543-B19F1CDE74A4

P2860

Q34004845-011C2036-081B-4FD9-88DC-37D9E763398D

Q34004845-01691754-770E-4818-B4D5-06E1ABBB6A4B

Q34004845-06CC02D6-2D21-4269-A29F-575E346C3967

Q34004845-16CDEC39-0A24-46BE-940B-15F648D8460F

Q34004845-1DC99A26-56E4-4893-A010-80993064D03E

Q34004845-22D43172-082E-48D9-BB42-760F6C4A85B6

Q34004845-2A627A32-428A-455A-87BE-95FB876F868B

Q34004845-2CAC3974-2F96-4128-A552-33B5A5A8BC48

Q34004845-2E0F21E3-6766-4C7F-8A83-2FDFA0AFACF9

Q34004845-2F60E917-685A-4201-B200-68F84CCB66AD

P304

Q34004845-00BF4AC1-4061-4E22-9302-75ECE3209DD4

P31

Q34004845-32041A20-EFE7-42BA-A604-CB295BB2198F

P356

Q34004845-6BCB6A6E-B25F-4AC8-8ED7-152BDE2C384E

P407

Q34004845-469B3A19-6ACA-4DE6-A683-CD176BB3421E

P433

Q34004845-6A6E0157-965A-4440-8676-052841EADABC

P478

Q34004845-CBD10A5C-17A0-4580-AA92-2C0B7011A2EB

P50

Q34004845-2AAE7C01-4232-4E3A-B21A-9351DB9F1C96

Q34004845-5BFE68AB-9571-4A3C-A1AD-B3FF2AF2AB6F

Q34004845-83EC8246-4D54-48A9-95B0-6D38E0F88E84

Q34004845-97FF65EA-7481-4B9F-A37F-C27DEC7BE630

P577

Q34004845-64ECAE9C-5EC3-4971-9F57-6E91B7D758FC

P5875

Q34004845-AC13705B-86B0-4DEB-9238-A7D6EF1C198D

P698

Q34004845-1805D773-FC7E-4B18-8D26-2A2E400BDFA7

P932

Q34004845-62282EAF-FD16-46B1-9786-4271779AE3AB

P356

PNAS.0910106107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Therapeutic potential of appro ...... m cells for spinal cord injury

@en

P2093

Eiji Ikeda

http://www.w3.org/2001/XMLSchema#string

Gentaro Kumagai

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Katoh

http://www.w3.org/2001/XMLSchema#string

Hisanobu Higashi

http://www.w3.org/2001/XMLSchema#string

Kanehiro Fujiyoshi

http://www.w3.org/2001/XMLSchema#string

Kazuhisa Kohda

http://www.w3.org/2001/XMLSchema#string

Kazuya Kitamura

http://www.w3.org/2001/XMLSchema#string

Kyoko Miura

http://www.w3.org/2001/XMLSchema#string

Makoto Nishino

http://www.w3.org/2001/XMLSchema#string

Masahiko Mukaino

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Generation of germline-competent induced pluripotent stem cells

Nuclear reprogramming and pluripotency

Stem cells for the treatment of neurological disorders

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

Mammalian neural stem cells

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

Generation of mouse induced pluripotent stem cells without viral vectors

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

P304

12704-12709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0910106107

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Michisuke Yuzaki

Shinya Yamanaka

P577

2010-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113516

http://www.w3.org/2001/XMLSchema#string

P698

20615974

http://www.w3.org/2001/XMLSchema#string

P932

2906548

http://www.w3.org/2001/XMLSchema#string